First Time Loading...

Incyte Corp
NASDAQ:INCY

Watchlist Manager
Incyte Corp Logo
Incyte Corp
NASDAQ:INCY
Watchlist
Price: 51.68 USD 0.98% Market Closed
Updated: Apr 29, 2024

Wall Street
Price Targets

INCY Price Targets Summary
Incyte Corp

Wall Street analysts forecast INCY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INCY is 76.86 USD with a low forecast of 61.61 USD and a high forecast of 96.6 USD.

Lowest
Price Target
61.61 USD
19% Upside
Average
Price Target
76.86 USD
49% Upside
Highest
Price Target
96.6 USD
87% Upside

INCY Last Price Targets
Incyte Corp

The latest public price target was made on Apr 25, 2024 by Jasper Hellweg from Argus Research , who expects INCY stock to rise by 35% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Jasper Hellweg
Argus Research
70 USD
Upside 35%
4 days ago
Apr 25, 2024
Incyte price target lowered to $70 from $80 at Argus
TheFly
Unknown Analyst
Cowen & Co.
100 USD
Upside 93%
1 year ago
Feb 8, 2023
Cowen & Co. Maintains Outperform on Incyte, Raises Price Target to $100
Benzinga
Jasper Hellweg
Argus Research
Price Target 70 USD
Upside/Downside 35%
View Source
Unknown Analyst
Cowen & Co.
Price Target 100 USD
Upside/Downside 93%
View Source
Incyte Corp Competitors:
Price Targets
RARE
Ultragenyx Pharmaceutical Inc
107% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
13% Upside
ADCT
ADC Therapeutics SA
140% Upside
87S
Roivant Sciences Ltd
48% Upside
IVA
Inventiva SA
274% Upside
NTLA
Intellia Therapeutics Inc
249% Upside
6855
Ascentage Pharma Group International
85% Upside
CIR
Circassia Group PLC
29% Upside

Revenue
Forecast

Revenue Estimate
Incyte Corp

For the last 8 years the compound annual growth rate for Incyte Corp's revenue is 22%. The projected CAGR for the next 3 years is 12%.

22%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Incyte Corp

For the last 8 years the compound annual growth rate for Incyte Corp's operating income is 38%. The projected CAGR for the next 3 years is 41%.

38%
Past Growth
41%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Net Income
Forecast

Net Income Estimate
Incyte Corp

For the last 8 years the compound annual growth rate for Incyte Corp's net income is 76%. The projected CAGR for the next 3 years is 37%.

76%
Past Growth
37%
Estimated Growth
Estimates Accuracy
-27%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INCY's stock price target?
Price Target
76.86 USD

According to Wall Street analysts, the average 1-year price target for INCY is 76.86 USD with a low forecast of 61.61 USD and a high forecast of 96.6 USD.

What is Incyte Corp's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Incyte Corp's revenue is 22%. The projected CAGR for the next 3 years is 12%.

What is Incyte Corp's Operating Income forecast?
Projected CAGR
41%

For the last 8 years the compound annual growth rate for Incyte Corp's operating income is 38%. The projected CAGR for the next 3 years is 41%.

What is Incyte Corp's Net Income forecast?
Projected CAGR
37%

For the last 8 years the compound annual growth rate for Incyte Corp's net income is 76%. The projected CAGR for the next 3 years is 37%.